D
Revolution Medicines, Inc. RVMD
$37.01 $0.531.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -812.06M -697.51M -600.09M -567.06M -519.21M
Total Depreciation and Amortization 12.68M 11.68M 10.72M 10.20M 9.46M
Total Amortization of Deferred Charges 1.10M 1.10M 1.10M 1.10M 1.10M
Total Other Non-Cash Items 62.88M 43.36M 30.43M 36.52M 32.38M
Change in Net Operating Assets 50.49M 50.06M 406.00K -20.46M -33.53M
Cash from Operations -684.90M -591.31M -557.44M -539.71M -509.79M
Capital Expenditure -15.46M -10.41M -10.31M -11.40M -10.42M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -380.59M -311.97M -544.09M -530.49M -432.65M
Cash from Investing -396.05M -322.38M -554.39M -541.89M -443.07M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 862.87M 863.79M 863.71M 88.15M 11.87M
Repurchase of Common Stock -- -- -- -4.03M -4.03M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 345.69M 95.69M 95.71M 840.83M 840.83M
Cash from Financing 1.21B 959.48M 959.41M 924.96M 848.68M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 127.61M 45.79M -152.42M -156.64M -104.18M